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The anchoring of microtubules (MTs) to subcellular structures is critical for cell shape, polarity, and motility. In
mammalian cells, the centrosome is a prominent MT anchoring structure. A number of proteins, including ninein,
p150Glued, and EB1, have been implicated in centrosomal MT anchoring, but the process is far from understood. Here we
show that CAP350 and FOP (FGFR1 oncogene partner) form a centrosomal complex required for MT anchoring. We show
that the C-terminal domain of CAP350 interacts directly with FOP and that both proteins localize to the centrosome
throughout the cell cycle. FOP also binds to EB1 and is required for localizing EB1 to the centrosome. Depletion of either
CAP350, FOP, or EB1 by siRNA causes loss of MT anchoring and profound disorganization of the MT network. These
results have implications for the mechanisms underlying MT anchoring at the centrosome and they attribute a key MT
anchoring function to two novel centrosomal proteins, CAP350 and FOP.
INTRODUCTION
In most animal cells, the centrosome plays an important role
in the organization of MT networks (Rieder et al., 2001;
Bornens, 2002; Nigg, 2004; Ou and Rattner, 2004; Doxsey et
al., 2005). A single centrosome is composed of two centrioles
that are surrounded by amorphous pericentriolar material
(PCM). These two centrioles (sometimes referred to as
mother and daughter) differ in structure, function and age
(state of maturity). In particular, the fully mature centriole is
characterized by the presence of appendages at its distal
end. MTs are nucleated from so-called -tubulin ring com-
plexes (-TuRCs; Moritz et al., 2004). These ring-shaped
multiprotein complexes are present within PCM associated
with both mother and daughter centrioles and, indeed, both
centrioles are competent to nucleate MTs (Piel et al., 2000).
Subsequent to nucleation, MTs are released (Keating et al.,
1997; Abal et al., 2002). So, in order to remain associated with
centrosomes, they need to be captured by centrosomal MT
anchoring activities (Dammermann et al., 2003). Anchoring
mechanisms remain incompletely understood, but the avail-
able evidence suggests that appendages of the mature cen-
triole play a prominent role in MT anchoring (Piel et al.,
2000). Moreover, transport of released MTs to appendages
was shown to require dynein/dynactin activity (Piel et al.,
2000; Clark and Meyer, 1999; Quintyne et al., 1999).
Several proteins have been shown to localize to centriole
appendages. These include ninein (Mogensen et al., 2000),
odf2/cenexin (Lange and Gull, 1995; Nakagawa et al., 2001;
Ishikawa et al., 2005), centriolin (Gromley et al., 2003), -tu-
bulin (Chang et al., 2003), Cep170 (Guarguaglini et al., 2005),
and CEP110 (Ou et al., 2002). An involvement in MT anchor-
ing has been clearly demonstrated for ninein (Mogensen et
al., 2000; Dammermann and Merdes, 2002; Abal et al., 2002;
Delgehyr et al., 2005). However, not all proteins implicated
in MT anchoring are concentrated at appendages. In partic-
ular, evidence for a role in MT anchoring has been reported
for PCM-1 (Dammermann and Merdes, 2002), BBS4 (Kim et
al., 2004), and CEP135 (Ohta et al., 2002).
The MT plus-end-associated protein EB1 (Askham et al.,
2002; Louie et al., 2004) and the dynein/dynactin complex
(Quintyne et al., 1999; Quintyne and Schroer, 2002) have also
been linked to MT anchoring. EB1 has attracted considerable
interest because of its ability to interact with the tumor
suppressor protein APC (adenomatous polyposis coli; Su et
al., 1995). EB1 prominently localizes to growing MT plus
ends and plays a role in the regulation of MT dynamics
(Berrueta et al., 1998; Tirnauer et al., 1999; Mimori-Kiyosue et
al., 2000; Nakamura et al., 2001). In addition, it associates
with centrosomes, consistent with a function in centrosomal
MT anchoring (Berrueta et al., 1998; Morrison et al., 1998;
Askham et al., 2002; Louie et al., 2004). Specifically, the
retention of MTs at the centrosome was shown to depend on
an interaction between EB1 and the dynactin subunit
p150Glued (Askham et al., 2002).
Here we have studied CAP350 and FOP, two centrosome
components identified in a recent proteomics study
(Andersen et al., 2003). We demonstrate that these two pro-
teins form a complex and that both are required for MT
anchoring to the centrosome. We further show that FOP
binds to EB1 and is responsible for the centrosome associa-
tion of this MT plus-end-tracking protein. CAP350 and FOP
thus add to a growing list of centrosomal proteins required
for MT anchoring to mammalian centrosomes, implying that
MT anchoring is a more complicated process than hitherto
surmised.
MATERIALS AND METHODS
Plasmid Constructions
The 3 region of a CAP350 cDNA clone (KIAA0480) was obtained from
Deutsches Ressourcenzentrum fu¨r Genomforschung (Berlin), and the over-
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lapping KIAA2443 cDNA was kindly provided by Dr. S. Sugano (Institute of
Medical Science, University of Tokyo, Japan). The missing 5 region was
amplified by RT-PCR from HeLa S3 total RNA, using sequence information
from GenBank (Accession No. AF287356). cDNAs were ligated to yield full-
length CAP350 cDNA, confirmed by DNA sequencing, and subcloned into
pCRII-TOPO (Invitrogen, Carlsbad, CA). The FOP cDNA has previously been
described (Andersen et al., 2003). N-terminally myc-tagged CAP350 and C-
terminally flag-tagged FOP were constructed in mammalian pCMV expres-
sion vectors by standard procedures. The EB1-GFP plasmid was a kind gift
from Dr. Y. Mimori-Kiyosue (KAN Research Institute, Kyoto, Japan).
For yeast two-hybrid screening, fragments of CAP350, FOP, and EB1 were
amplified by PCR and subcloned into pACT2 (CLONTECH Laboratories, Palo
Alto, CA) or the two-hybrid bait vector pFBT9 (a version of pGBT9; CLON-
TECH Laboratories; modified to encode kanamycin resistance; kindly pro-
vided by Dr. F. Barr). Transformed yeast samples were plated on synthetic
media either lacking leucine and tryptophan (LW) or lacking leucine, tryp-
tophan, histidine, and adenine, with 2% (wt/vol) glucose as the carbon source
(QDO). All results were confirmed by streaking several independent colonies
on both selective (QDO) and nonselective (LW) plates.
Antibody Production
To generate a goat polyclonal antibody against CAP350, a fragment spanning
residues 2115–2643 was fused to glutathione-S-transferase (GST), purified
from Escherichia coli, and used as immunogen (500 g protein for first injec-
tion, followed by 350 g for first boost and 250 g for second boost). Rabbit
polyclonal anti-FOP antibodies were raised against full-length protein ex-
pressed in E. coli (Charles River Laboratories, St. Alban les Elbeuf, France).
Cell Culture, RNA Interference, and Immunofluorescence
Microscopy
Human cervical carcinoma (HeLa S3), osteosarcoma (U2OS), epithelial ade-
nocarcinoma (A549), and embryonal kidney cells (HEK293) as well as African
green monkey kidney cells (COS7), were all grown at 37C and 5% CO2 in
DMEM (Invitrogen-BRL), supplemented with 10% fetal calf serum and pen-
icillin-streptomycin (100 IU/ml and 100 mg/ml, respectively).
RNA interference was performed on HeLa S3, A549 cells, or U2OS cells.
Transfections with duplex RNA were carried out using oligofectamine (In-
vitrogen) for 72 or 96 h, respectively. The following siRNA duplex oligonu-
cleotides were used: CAP350: 5ATGAACGATATCAGTGCTATA 3 (oligo 1)
and 5 CAGGTAGTAGTCATCTTATAA 3 (oligo 2; QIAGEN, Hilden, Ger-
many); FOP: 5AAGTGATCAGGCGCTGTCAAC 3 (oligo 1; Dharmacon Re-
search, Boulder, CO) and 5 CTCGAAGGTCGAGAGAATTTA 3 (oligo 2;
QIAGEN).
The siRNA duplexes used to deplete pericentrin (Dammermann and Mer-
des, 2002) and EB1 (Louie et al., 2004) were designed as described previously,
and the duplex GL2 (Elbashir et al., 2001) was used for control.
Immunofluorescence (IF) microscopy was performed as described previ-
ously (Meraldi et al., 2002). Cells were grown on coverslips and fixed for 10
min in cold methanol. Primary antibodies were goat anti-CAP350 serum
(1:2000), rabbit anti-FOP (R144) serum (1:1000), affinity-purified rabbit anti-
pericentrin B antibody (kind gift of Dr. M. Takahashi, used as described
previously; Takahashi et al., 2002), mouse anti-EB1 (1:300, BD Transduction
Laboratories, Lexington, KY; Cat. 610535), mouse anti--tubulin-FITC (1:1000,
DM1A, Sigma, St. Louis, MO) and mouse anti--tubulin antibody (1:1000,
GTU-88, Sigma). Secondary reagents were Alexa-Fluor-555-conjugated goat
anti-mouse, Alexa-Fluor-488-conjugated goat anti-rabbit, Cy3-, Cy5-, and
Cy2-conjugated donkey anti-mouse, anti-rabbit, and anti-goat IgG antibodies
(1:1000, Molecular Probes, Eugene, OR). DNA was stained with 4,6-dia-
midino-2-phenylindole (DAPI, 2 g/ml). IF microscopy was performed using
a Zeiss Axioplan II microscope with 40 and 63 oil immersion objectives,
respectively. Photographs were taken using a Micromax 1300  1030 pixel
CCD camera (Princeton Instruments, Princeton, NJ) with Metavue software
(Universal Imaging, West Chester, PA). Images were processed with Adobe
Photoshop software (Adobe Systems, San Jose, CA).
Cell Extracts and Immunoprecipitation Experiments
For immunoprecipitation experiments, HEK293T cells were washed once
with phosphate-buffered saline and lysed in 20 mM Tris-HCl, pH 7.4, 100 mM
KCl, 0.1% NP40, 1 mM EDTA, 10% glycerol, and 50 mM NaF plus protease
inhibitors (Roche, Grenzach-Wyhlen, Germany) for 30 min on ice. Lysates
were clarified at 16,000  g at 4C for 8 min and preabsorbed on protein A
(Bio-Rad Laboratories, Richmond, CA) or protein-G beads (Amersham, Pis-
cataway, NJ) for 30 min at 4C. Equal amounts of precleared lysates were
incubated with 20 l beads bearing 5 g of goat anti-CAP350, rabbit anti-FOP,
and rabbit IgG, or sheep IgG for control, at 4C for 2 h. Immunoprecipitates
were washed three times in wash buffer (20 mM Tris-HCl, pH 7.4, 250 mM
KCl, 0.1% NP40, 1 mM EDTA, 10% glycerol, and 50 mM NaF) and resus-
pended in gel sample buffer.
For immunoprecipitation experiments performed with overexpressed FOP-
FLAG and EB1-GFP, HEK293T cells were collected after transfection for 36 h.
Cells were immunoprecipitated with anti-FLAG M2 beads (Sigma), and
bound proteins were eluted with 0.8 mg of FLAG peptide/ml in a total
volume of 30 l (Zhou et al., 1998).
MT Regrowth Assays
HeLa S3 cells were transfected with different siRNA duplexes and MT re-
growth assays were performed as described previously (Fry et al., 1998). In
brief, MTs were depolymerized on ice for 30 min and regrowth was induced
by incubation in prewarmed medium (37C). For better visualization of MTs
by IF, the cells were preextracted for 30 s with MT-stabilizing extraction buffer
(20 mM TrisCl, pH 7.0, 100 mM NaCl, 300 mM sucrose, 3 mM MgCl2, 1 mM
EGTA, 0.5% Triton X-100) before methanol fixation (Yan et al., 2003).
RESULTS
CAP350 Is a Cell Cycle-regulated Centrosome Protein
CAP350 was predicted to be a centrosomal protein by a
protein correlation profiling (phencyclidine) algorithm used
in a mass spectrometry-based proteomic study of the human
centrosome (Andersen et al., 2003). In support of a MT-
related function, CAP350 carries a distinctive CAP_Gly mo-
tif (Figure 1A), a domain of70 amino acids with conserved
glycine and hydrophobic residues (Riehemann and Sorg,
1993). Similar motifs have previously been described in sev-
eral MT binding proteins, notably CLIP-170 (Diamantopou-
los et al., 1999), CLIP-115 (Hoogenraad et al., 2000), and
p150Glued (Vaughan et al., 2002). To study endogenous
CAP350 in human cells, a goat polyclonal antibody was
raised against a recombinant protein spanning residues
2115–2643. As shown by Western blotting, this antibody
specifically recognized a protein of the expected molecular
weight (350 kDa) in whole HeLa S3 cell lysates (Figure 1C;
for the complete gel see Figure 2A). To examine the expres-
sion of CAP350 during the cell cycle, lysates were prepared
from synchronized HeLa cells (Sillje et al., 1999) and ana-
lyzed by Western blotting. CAP350 protein was detectable at
relatively constant levels during all stages of the cell cycle
but displayed a retarded electrophoretic mobility during M
phase, suggesting that it might be phosphorylated (Figure
1C). This possibility was confirmed by in vitro dephosphor-
ylation, demonstrating that CAP350 is a substrate for mito-
sis-specific phosphorylation (Figure 1D). IF staining of asyn-
chronously growing HeLa or U2OS cells with anti-CAP350
antibody revealed two closely spaced dots colocalizing with
-tubulin, indicating that CAP350 associates with centro-
somes throughout the cell cycle (Figure 1B and unpublished
data). This centrosome association was also seen in nocoda-
zole-treated cells, indicating that it was not dependent on
MTs (unpublished data). During M phase, when -tubulin
staining of poles was rather diffuse, two CAP350-positive
dots could still be seen at each spindle pole, suggesting an
association with centrioles (Figure 1B, insets). Additionally,
association of CAP350 with MTs could be observed in mi-
totic but not interphase cells, and again, some colocalization
with -tubulin on spindle microtubules was apparent (Fig-
ure 1B). Taken together, these results identify CAP350 as a
core component of the human centrosome, confirming the
prediction of the proteomics study (Andersen et al., 2003).
Specifically, our data demonstrate that endogenous Cap350
localizes specifically to centrosomes and, to a lesser extent,
to spindle MTs (Figure 1B). In contrast to a recent study
detecting CAP350 at centrosomes but emphasizing a role of
this protein in the regulation of nuclear hormone receptors
(Patel et al., 2005), we could not detect significant amounts of
endogenous CAP350 within the nucleus.
Depletion of CAP350 Affects MT Anchoring
To explore the function of CAP350 in living cells, siRNA-
mediated protein depletion experiments were performed.
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HeLa S3 or A549 cells were transfected for 72 h with either
control (GL2; Elbashir et al., 2001) or one of two distinct
CAP350-targeting siRNA oligonucleotide duplexes (oligo-1,
oligo-2). As shown by Western blotting of HeLa total cell
lysates, both CAP350 siRNA duplexes caused a strong re-
duction in CAP350 protein levels (Figure 2A). Depletion of
the CAP350 protein could also be confirmed by IF micros-
copy with anti-CAP350 antibody (Figure 2, B and C). When
compared with the astral MT arrays seen in cells treated
with control GL2, cells depleted of CAP350 showed unfo-
cused, disorganized MT networks (Figure 2, B and C).
To explore the mechanism underlying the phenotype ob-
served in CAP350-depleted cells, we next carried out MT
regrowth assays, using both the GL2 duplex and pericentrin-
A/B-specific siRNA for control (Figure 3). After depolymer-
ization of MTs, the regrowth of MT asters was monitored at
various time points between 1 and 10 min. IF microscopy
(Figure 3, A–C) and quantitative analyses (Figure 3, D–F) of
CAP350-depleted cells revealed that initial MT nucleation at
the centrosome occurred (near-)normally, with at most a
minor delay in aster formation, but at later time points
75% of the CAP350 depleted cells showed disorganized
and unfocused MTs, indicating that MTs could be nucleated
but not retained at the centrosome. Under comparable con-
ditions, the depletion of pericentrin did not affect either the
nucleation or the anchoring of MTs. Taken together, these
results indicate that CAP350 is not required for MT nucle-
ation but necessary for MT anchoring at the centrosome.
A Centrosomal Protein, FOP (FGFR1 oncogene partner),
Interacts with CAP350
To better understand the role of CAP350 in MT anchoring,
we searched for interacting proteins. Specifically, we carried
out yeast two-hybrid screens with different fragments of
CAP350 as bait and a testis cDNA library as prey. By using
a C-terminal CAP350 fragment (residues 2159–3117) as bait,
we identified 15 independent clones all expressing full-
length FOP. This protein was originally identified as a fusion
partner with fibroblast growth factor receptor 1 (FGFR1) in
oncoproteins giving rise to stem cell myeloproliferative dis-
orders (Popovici et al., 1999; Guasch et al., 2001; Vizmanos et
al., 2004). Subsequently, FOP was shown to be a centrosomal
protein (Andersen et al., 2003; Delaval et al., 2005b). Interest-
ingly, FOP contains a LisH motif (Figure 4A), which in other
proteins has been implicated in MT dynamics (Emes and
Ponting, 2001; Figure 4A).
A rabbit antibody (R144) raised against full-length FOP
labeled the centrosome throughout the cell cycle and this
staining could readily be abolished by antigen competition
Figure 1. CAP350 localizes to the centrosome and is phosphory-
lated in M phase. (A) Schematic representation of CAP350, indicat-
ing the CAP_Gly motif and the domain (residues 2115–2643 aa)
used for antibody production. (B) IF staining in U2OS cells of
endogenous CAP350 (left) and -tubulin (middle). DNA (right) was
stained with DAPI. Insets shows enlargement of the centriolar stain-
ing of CAP350 and -tubulin at the poles. Bar, 10 m. (C) CAP350
is modified in M phase. HeLa S3 were released from a nocodazole
block, and samples were taken for Western blot analysis at the time
points indicated (T0–T4.0 in hours). For comparison, asynchro-
nously growing cells (Asy) were analyzed in parallel. (D) CAP350 is
phosphorylated during mitosis. CAP350 was immunoprecipitated
from asynchronously growing (Asy) or nocodazole-arrested (M)
HeLa cells and treated with () or without () calf intestinal phos-
phatase (CIP) in the presence () or absence () of phosphatase
inhibitors. Samples were separated by 6% SDS-PAGE and probed
by Western blotting.
Figure 2. Depletion of CAP350 causes dis-
organization of the MT network. (A) Western
blotting shows effective siRNA-mediated de-
pletion of CAP350 in HeLa S3 cells. Cells
were transfected with GL2 or CAP350-spe-
cific oligonucleotide duplexes for 72 h. Equal
amounts of protein were separated by SDS-
PAGE and probed by Western blotting with
anti-CAP350 antibody (top) and anti--tubu-
lin antibody for loading control (bottom). (B
and C) IF staining of CAP-350 depleted (bot-
tom) and control (top) HeLa S3 (B) and A549
cells (C) with antibodies to -tubulin. Note that
CAP350-depleted cells lack radial MT arrays
focused on the centrosome. Bar, 10 m.
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(Figure 4B and unpublished data). FOP colocalized with
-tubulin in interphase cells and, similar to CAP350 (Figure
1B), two bright FOP-positive spots were observed at each
spindle pole of mitotic cells (Figure 4B). Moreover, a small
portion of FOP could be seen to associate with spindle MTs
(Figure 4B). These IF results indicate that FOP colocalizes
with CAP350 throughout the cell cycle. By Western blotting,
the anti-FOP antibody specifically recognized a 50 kDa
protein in whole cell extracts prepared from HEK293T,
U2OS, or HeLa S3. Attesting to the specificity of this reac-
tion, FOP immunoreactivity disappeared after siRNA-medi-
ated depletion of FOP (see Figure 7). Similar to CAP350, FOP
also displayed a retarded mobility in M phase samples, due
to phosphorylation (Figure 4 D).
To confirm the yeast two-hybrid results and determine
whether CAP350 and FOP interact in human cells, coimmu-
noprecipitation experiments were carried out. First, experi-
ments were performed with lysates prepared from 293T cell
co-overexpressing FOP-FLAG and the myc-tagged C-termi-
nal CAP350 fragment (residue 2159–3117). As shown in
Figure 5A, FLAG-tagged FOP was specifically coprecipi-
tated with the myc-tagged CAP350 fragment (compare lanes
4 and 3) and, in a reciprocal experiment, the C-terminal
CAP350 fragment was specifically coprecipitated with
FLAG-tagged FOP (compare lanes 6 and 5). Furthermore,
endogenous CAP350 could readily be detected in the FLAG-
tagged FOP immunoprecipitate (lane 12), but not in the
control sample (lane 11). To demonstrate an interaction be-
tween endogenous proteins, coimmunoprecipitation exper-
iments were then carried out with anti-CAP350 and anti-
FOP antibodies. As shown in Figure 5B, CAP350 could
readily and specifically be coprecipitated with FOP (com-
pare lanes 3 and 2), and vice versa (compare lanes 6 and 5).
Taken together, these data clearly demonstrate that FOP
interacts with CAP350 in vivo and that this interaction re-
quires the C-terminal part of CAP350.
To more precisely map the interaction domains between
CAP350 and FOP, yeast two-hybrid experiments were per-
Figure 3. Depletion of CAP350 affects MT anchoring. HeLa S3 cells were transfected with GL2 (A), CAP350–2 (B), and pericentrin A/B
siRNA (C) oligonucleotide duplexes. They were then subjected to MT regrowth assays and fixed at the time points indicated. CAP350 and
pericentrin were visualized with appropriate antibodies (inset in C shows positive staining for pericentrin in GL2-treated control cells) and
MTs were stained with FITC-labeled anti--tubulin antibody. Bar, 10 m. (D–F) Transfected cells were classified according to their failure to
nucleate MTs (white bars), or nucleate MTs and then form asters (gray bars) or nonfocused MT networks (black bars). Histograms show
results from three independent experiments, counting 300 cells each, and error bars indicate SDs.
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formed (Figure 6). These studies showed that the C-terminal
47 amino acids of CAP350 were sufficient for the interaction
with FOP (Figure 6A) and the N-terminal 175 residues of
FOP, including the LisH domain, were required for binding
to CAP350 (Figure 6B). The LisH motif was not sufficient for
binding of FOP to CAP350, as indicated by the inability of
FOP1–106 to bind. However, the LisH motif was clearly
required in that point mutations within this motif severely
reduced or abolished binding (Figure 6B). Interestingly,
these studies also revealed a strict correlation between the
ability of FOP mutants to interact with CAP350 and their
ability to localize to the centrosome (Figure 6B), suggesting
that the centrosome association of FOP is mediated by
CAP350.
Requirements for CAP350 and FOP Localization
To further explore the possibility that CAP350 and FOP
might determine each other’s localization, the two proteins
were depleted by siRNA, using two different oligonucleo-
tide duplexes (oligo1 and oligo2) for targeting each protein
(Figure 7). Depletion efficiency was demonstrated by both
Western blotting (Figures 2 and 7C, respectively) and IF
microscopy (Figures 2 and 7, B and D). Depletion of CAP350
virtually abolished the association of FOP with centrosomes
in both interphase and M phase cells (Figure 7B), confirming
and extending the data shown in Figure 6. In contrast,
depletion of FOP did not detectably influence the centro-
some association of CAP350 in interphase cells (Figure 7D).
Interestingly, however, it abolished CAP350 association
with spindle MTs in M phase cells and instead caused the
accumulation of CAP350 at spindle poles in (compare Figure
7D with Figure 1B). These results demonstrate that CAP350
is required for recruiting FOP to the centrosome and that
FOP is necessary for CAP350 association with spindle MTs.
By deletion analysis, we found that the central part of
CAP350 (residues 1000–2159) was required for centrosome
association, but the CAP_Gly motif was not necessary (un-
published data). Exactly how CAP350 is targeted to the
centrosome remains to be established.
FOP Interacts with the TIP Protein EB1
When FLAG-tagged FOP was expressed in cells, it colocal-
ized with -tubulin at centrosomes as expected, at least
when expressed at relatively low levels (Figure 8A, top).
Remarkably, however, at higher expression levels, FOP
showed a pronounced tendency to associate with MT plus
ends, as demonstrated by double-labeling with the plus-end
marker (TIP) protein, EB1 (Figure 8A, bottom). Consider-
ing that two different TIP proteins, EB1 and p150Glued,
have previously been implicated in MT anchoring (Quintyne
et al., 1999; Askham et al., 2002; Louie et al., 2004), we asked
whether FOP could interact with either EB1 or p150Glued.
Yeast two-hybrid experiments revealed no interaction be-
tween FOP and p150Glued (unpublished data), but binding
could readily be seen with EB1 (Figure 8C). Moreover, the
ability of different FOP mutants to localize to MT plus ends
was correlated with their ability to interact with EB1 (Figure
8C). An interaction between FOP and EB1 could also be
Figure 4. FOP is a centrosomal protein and
phosphorylated in mitosis. (A) Schematic
representation of FOP, indicating the LisH
domain (residues 69–102). (B) Subcellular lo-
calization of FOP at various cell cycle stages.
U2OS were labeled with anti-FOP antibody
(top) and DAPI to visualize DNA (bottom).
Bar, 10 m. (C) Western blotting of total
HEK293T, U2OS, and HeLa S3 cell extracts
with affinity purified anti-FOP antibody. Cell
extracts, 15 g, were used for each lane. (D)
FOP was immunoprecipitated from asyn-
chronously growing (Asy) or nocodazole-ar-
rested (M) HeLa cells and treated with () or
without () calf intestinal phosphatase (CIP)
in the presence () or absence () of phos-
phatase inhibitors. Samples were separated
by 12% SDS-PAGE and probed by Western
blotting.
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demonstrated by coimmunoprecipitation from 293T cell ly-
sates coexpressing GFP-tagged EB1 and FLAG-tagged FOP
(Figure 8B). However, we have so far been unable to detect
endogenous EB1 in anti-FOP immunoprecipitates (unpub-
lished data), suggesting that the interaction is transient
and/or that only a small amount of EB1 interacts with FOP
at the centrosome.
Prompted by the above findings, we next asked whether
depletion of endogenous FOP would impair the localization
of EB1 at either MT plus ends or centrosomes. To allow the
visualization of EB1 at the centrosome, MTs were depoly-
merized by nocodazole treatment (Fry et al., 1998) and
CAP350 was used as a centrosome marker. Depletion of FOP
virtually abolished centrosome localization of EB1 (Figure
8D) but did not detectably influence its MT plus-end local-
ization (unpublished data). Moreover, overexpression of a
FOP-binding C-terminal fragment of CAP350 (2159–3117) in
COS7 cells caused the displacement of both endogenous
FOP and EB1 from centrosomes (unpublished data). These
data indicate that a CAP350-FOP complex is required for the
accumulation of EB1 at the centrosome.
CAP350, FOP, and EB1 Are All Required for MT
Anchoring
Having established that CAP350, FOP, and EB1 interact, we
sought evidence to demonstrate that all three proteins are
required for MT anchoring at the centrosome. When either
FOP or EB1 were depleted by siRNA, the depleted cells
showed disorganized MT arrays (Figure 9, A and B), very
similar to the results observed upon depletion of CAP350
(Figure 2B). Moreover, when FOP was displaced from the
centrosome by overexpression of a C-terminal CAP350 frag-
ment (2159–3117), the MT network of COS7 cells also be-
came disorganized (Figure 9C). To determine whether the
disorganization caused by FOP depletion was the result of
impaired MT anchoring, MT regrowth assays were per-
formed in siRNA-treated cells (Figure 10). To assess MT
nucleation and MT anchoring, respectively, samples were
Figure 5. CAP350 interacts with FOP in vivo. (A) FOP interacts
with a C-terminal fragment of CAP350. Immunoprecipitation exper-
iments were performed on lysates from 293T cells after cotransfec-
tion with the indicated plasmids. Antibodies used were anti-myc
(lanes 3 and 4) and anti-FLAG (lanes 5 and 6), coupled to beads.
Immunoprecipitated proteins were then analyzed by Western blot-
ting, using the indicated antibodies, and whole cell lysates were
analyzed in parallel (lanes 1 and 2). In a separate experiment,
anti-FLAG immunoprecipitates were also separated by 6% SDS-
PAGE and probed with anti-CAP350 antibody to detect endogenous
CAP350 (lanes 9–12). (B) Endogenous FOP interacts with endoge-
nous CAP350. HEK293T cell extracts were immunoprecipitated
with control rabbit IgG (lane 2) or goat IgG (lane 5) and anti-FOP
(lane 3) or anti-CAP350 antibody (lanes 6). Immunoprecipitates
were subject to Western blotting with anti-FOP (top) or anti-CAP350
(bottom) antibodies; whole cell lysates are shown in lanes 2 and 4.
Figure 6. Mapping the interaction domain
between CAP350 and FOP. (A) Summary of
FOP interactions, as determined by yeast
two-hybrid analyses with different C-termi-
nal constructs of CAP350, and of centrosome
localizations, as determined by IF micros-
copy. (B) Yeast two-hybrid analyses of inter-
actions between the indicated C-terminal
CAP350 fragment and FOP constructs. The
wild-type and mutant FOP constructs ana-
lyzed are indicated schematically on the left
and their ability to localize to the centrosome
on the right. The abbreviation FOP(3M)
stands for FOPV74FL82QE97K. The central
panel shows the results of growing trans-
formed yeast cells on selective medium
(QDO), to test for interactions with the
CAP350 bait. BD, binding domain; AD, acti-
vation domain.
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analyzed at different time points after induction of regrowth.
After depletion of FOP, MTs were nucleated as efficiently as
in the GL2-treated controls (Figure 10, compare 1-min time
points), but with increasing time 80% of the FOP-depleted
cells lacked focused radial MT arrays, indicating that MTs
could not be retained at the centrosome (Figure 10, compare
10-min time points). In the case of EB1-depleted cells, MTs
were also nucleated, although nucleation was delayed (un-
published data), presumably because polymerized MTs
were less stable in the absence of EB1 (Louie et al., 2004).
Similar to the FOP depleted cells, most of the EB1-depleted
cells subsequently failed to develop focused MT arrays after
10–15 min of regrowth (unpublished data; see Figure 9B).
These data demonstrate that MTs could be nucleated in the
absence of either FOP or EB1, but they could not subse-
quently be retained at the centrosome.
Taken together, our data indicate that CAP350 provides a
docking site for FOP at the centrosome. In turn, FOP then
contributes to recruiting EB1, and all three proteins cooper-
ate in MT anchoring at the centrosome.
DISCUSSION
The centrosome is best known for its role in MT nucleation,
but recent studies provide increasing evidence that this or-
ganelle is also a major site of MT anchoring in many animal
cells (Bornens, 2002; Ou and Rattner, 2004). MT anchoring at
the centrosome results in radial MT arrays, and although
MT anchoring is dependent on MT nucleation, it clearly
represents a distinct aspect of centrosome function. A num-
ber of proteins have previously been implicated in MT an-
choring (Mogensen et al., 2000; Askham et al., 2002; Dam-
mermann and Merdes, 2002; Ohta et al., 2002; Kim et al.,
2004; Delgehyr et al., 2005), but our understanding of the
Figure 7. Effect of CAP350 depletion on FOP localization and vice
versa. (A, B, and D) FOP targeting to centrosome requires CAP350,
whereas spindle association of CAP350 requires FOP. HeLa S3 cells
were treated for 72 h with the GL2 control duplex (A), a CAP350-
specific duplex (B), or a FOP-specific duplex (D) and then interphase
and mitotic cells were analyzed by IF microscopy, using the anti-
bodies indicated. Bar, 10 m. (C) Western blotting shows effective
depletion of FOP by 72-h treatment with two different siRNA oli-
gonucleotide duplexes. Equal amounts of protein were separated by
SDS-PAGE and probed by Western blotting with anti-FOP antibody
(top) and anti--tubulin antibody as a loading control (bottom).
Figure 8. FOP interacts with EB1 and is required for its centrosome
localization. (A) U2OS cells were transfected with FLAG-tagged
FOP and costained with anti-FLAG and either anti--tubulin or
anti-EB1 antibodies. Bar, 10 m. (B) FOP interacts with EB1 in vivo.
HEK293T cells were transfected for 36 h with GFP-tagged EB1 and
FLAG-tagged FOP (lanes 1 and 4) or empty FLAG vector (lanes 2
and 3). After lysis, immunoprecipitations were performed with
anti-FLAG antibodies coupled to beads and proteins were subject to
SDS-PAGE and transferred to membranes. Western blots were
probed with anti-FLAG (bottom) or anti-GFP (top) antibodies. (C)
Yeast two-hybrid analysis of the interaction between EB1 and var-
ious FOP constructs. The wild-type and mutant FOP constructs
analyzed are indicated schematically on the left and their ability to
localize to MT plus ends, as determined by transient transfection, on
the right. The abbreviation FOP(3M) stands for FOPV74FL82QE97K.
The central panel shows the results of growing transformed yeast
cells on selective medium (QDO), to test for interactions with the
CAP350 bait, and on nonselective medium (LW) to control for
viability. BD, binding domain; AD, activation domain. (D) U2OS
cells were transfected with a FOP-specific siRNA duplex for 96 h,
treated for 4 h with 6 g/ml nocodazole, and then subjected to IF
microscopy, using anti-FOP (left), anti-EB1 (middle), and anti-
CAP350 (right) antibodies. Bar, 10 m.
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structures and mechanisms required for this important pro-
cess remains limited. Here we characterize CAP350 and
FOP, two novel proteins recently shown or predicted to
localize to the centrosome (Andersen et al., 2003). We dem-
onstrate that both proteins localize to the centrosome through-
out the cell cycle. Moreover, we show that CAP350 and FOP
interact directly with each other, and that both are required for
MT anchoring. Finally, we identify EB1 as an interaction part-
ner of FOP and confirm a role for this TIP protein in MT
anchoring (Askham et al., 2002; Louie et al., 2004).
Database searches readily identify CAP350 and FOP ho-
mologues in vertebrates but we have been unable to find
obvious homologues in invertebrates or yeast. Interestingly,
proteins showing partial sequence similarity to FOP have
Figure 9. Depletion of FOP or EB1 causes
disorganization of the MT network. (A and
B) HeLa S3 cells were transfected for 72 h
with the indicated siRNA duplexes and then
subjected to IF staining with the indicated
antibodies. Note that both FOP- and EB1-
depleted cells lack radial MT arrays focused
on the centrosome. Bar, 10 m. (C) COS7 cells
were transfected for 48 h with the myc-
tagged C-terminal CAP350 fragment, a do-
main known to bind FOP (Figure 6), and then
stained with anti-myc (left), anti-FOP (mid-
dle), and anti--tubulin antibodies. Note the
transfected cells, but not neighboring con-
trols, lack radial MT arrays. Bar, 10 m.
Figure 10. Depletion of FOP affects MT anchoring. HeLa S3 cells were transfected with GL2 (A) or a FOP-specific siRNA oligonucleotide
duplex (B). They were then subjected to MT regrowth assays and fixed at the time points indicated. FOP was visualized with anti-FOP
antibodies and MTs were stained with FITC-labeled anti--tubulin antibody. Bar, 10 m. (C) Transfected cells were classified according to
their failure to nucleate MTs (white bars), or nucleate MTs and then form asters (gray bars) or nonfocused MT networks (black bars).
Histograms show results from three independent experiments, counting 300 cells each, and error bars indicate SDs.
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also been identified in the plant Arabidopsis (Traas et al.,
1995;Delaval et al., 2005a). Although higher plants lack cen-
trosomes, the products of these FOP-related plant genes
(termed tonneau-1a and -1b) also function in MT organiza-
tion (Delaval et al., 2005a). Both CAP350 and FOP carry
structural motifs that have also been observed in other pro-
teins implicated in cytoskeletal networks.
CAP350 harbors a CAP_Gly motif, a domain of 70 res-
idues (Riehemann and Sorg, 1993). Similar motifs have been
shown to be essential for MT association of CLIP-170 (Dia-
mantopoulos et al., 1999), CLIP-115 (Hoogenraad et al., 2000),
and p150Glued (Vaughan et al., 2002), but the precise role of
CAP_Gly motifs is not well understood. Our study shows
that the CAP_Gly motif of CAP350 was not required for
either binding to FOP or centrosome localization of CAP350.
Instead, mapping studies identified the last 47 C-terminal
amino acids of CAP350 as being both necessary and suffi-
cient for FOP binding. The structure of this fragment is
unknown, but its functional importance is confirmed by a
very high degree of sequence conservation in the C-termini
of vertebrate CAP350 homologues.
FOP has originally been identified as a fusion partner for
FGF-receptor 1 in chromosomal translocations giving rise to
myeloproliferative disorders (Popovici et al., 1999; Guasch et
al., 2001; Vizmanos et al., 2004). Although it is well estab-
lished that constitutive activation of tyrosine kinase activity
is critical for oncogenesis in leukemia patients carrying chi-
meric kinase fusion proteins, the role of FOP has not been
thoroughly investigated. A priori, it is possible that FOP
merely contributes an activating dimerization domain to the
FGF-receptor kinase. Alternatively, it is attractive to specu-
late that targeting of the FOP-FGF-receptor fusion protein to
the centrosome contributes to oncogenesis (Delaval et al.,
2005b). The most striking feature of FOP is the presence of a
LisH motif within the N-terminal half of the protein. Named
after the lissencephaly gene product Lis1 (Emes and Pont-
ing, 2001), LisH motifs have been implicated in both MT
dynamics (Traas et al., 1995; Sapir et al., 1999) and protein
dimerization (Cahana et al., 2001). In the case of FOP, we
have shown that the LisH motif is required but not sufficient
for complex formation with CAP350. In contrast, it was not
required for FOP binding to EB1.
The MT plus-end tracking protein EB1 is well known to
interact with the tumor suppressor APC (adenomatous pol-
yposis coli; Su et al., 1995) and also with the dynactin com-
ponent p150Glued (Berrueta et al., 1999; Askham et al., 2002;
Ligon et al., 2003; Hayashi et al., 2005). Most of the studies on
EB1 have emphasized its roles in MT stabilization at MT
plus ends (Mimori-Kiyosue et al., 2000, 2005; Tirnauer and
Bierer, 2000; Nakamura et al., 2001). However, EB1 has also
been detected at the centrosome (Berrueta et al., 1998; Mor-
rison et al., 1998), where it has been implicated in MT an-
choring (Askham et al., 2002; Louie et al., 2004). Interestingly,
this latter function requires the ability of EB1 to interact with
p150Glued (Askham et al., 2002). Here, we have discovered
that EB1 also interacts with FOP. Although the interface
between EB1 and p150Glued has recently been resolved by
crystallography (Hayashi et al., 2005), we have presently no
information on how EB1 interacts with FOP. Importantly,
however, FOP is clearly required for the accumulation of
EB1 at the centrosome.
Our data demonstrate that all three proteins studied here,
CAP350, FOP, and EB1, are required for MT anchoring.
Whether they play a direct role in anchoring itself or instead
contribute to the organization of MT minus ends requires
further study. Our results also point to a hierarchy in the
centrosome association of the three proteins. In the absence
of CAP350, FOP could not localize to centrosomes. More-
over, overexpression of a CAP350 fragment spanning the
FOP interaction domain resulted in the displacement of FOP
from centrosomes. On the other hand, FOP was not required
for the centrosome association of CAP350, but its absence
impaired the ability of CAP350 to bind to spindle MTs
during mitosis. CAP350 and FOP constitute genuine centro-
somal proteins, but the properties of EB1 suggest that it acts
as a more distal component in MT anchoring.
How exactly the three proteins characterized here,
CAP350, FOP, and EB1, cooperate mechanistically in MT
anchoring remains to be determined. One attractive possi-
bility is that a CAP350-FOP complex provides centrosomal
docking sites for EB1, which then cooperates with the
p150Glued-dynactin complex to capture newly nucleated
MTs after their release from -TuRCs (Askham et al., 2002).
In the future, it will be important to investigate how the
CAP350-FOP complex interacts with other centrosome com-
ponents implicated in MT anchoring, notably ninein (Mo-
gensen et al., 2000; Abal et al., 2002; Dammermann and
Merdes, 2002; Delgehyr et al., 2005) and the BBS4/PCM-1
complex (Dammermann and Merdes, 2002; Kim et al., 2004).
Finally, we note that MT anchoring to the interphase cen-
trosome is expected to differ from MT anchoring to the
mitotic spindle pole (Khodjakov et al., 2000; Bornens, 2002).
In this context it may be relevant that both CAP350 and FOP
were found to be subject to mitotic phosphorylation. It will
be interesting, therefore, to explore the cell cycle regulation
of these proteins.
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